日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating GPT-4 as an academic support tool for clinicians: a comparative analysis of case records from the literature

评估 GPT-4 作为临床医生学术支持工具的有效性:文献病例记录的比较分析

Fabre, B L; Magalhaes Filho, M A F; Aguiar, P N Jr; da Costa, F M; Gutierres, B; William, W N Jr; Del Giglio, A

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

骨转换生物标志物可识别去势抵抗性前列腺癌伴骨转移男性患者的独特预后风险组:SWOG S0421 研究结果

Lara, P N Jr; Plets, M; Tangen, C; Gertz, E; Vogelzang, N J; Hussain, M; Twardowski, P W; Garzotto, M G; Monk, J P; Carducci, M; Goldkorn, A; Mack, P C; Thompson, I; Van Loan, M; Quinn, D I

A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma

一项MK-2206与依维莫司治疗难治性肾细胞癌的随机II期研究

Jonasch, E; Hasanov, E; Corn, P G; Moss, T; Shaw, K R; Stovall, S; Marcott, V; Gan, B; Bird, S; Wang, X; Do, K A; Altamirano, P F; Zurita, A J; Doyle, L A; Lara, P N Jr; Tannir, N M

Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patients

对多西他赛预处理过的去势抵抗性前列腺癌患者进行低剂量酮康唑联合氢化可的松治疗的前瞻性评估

Lo, E N; Beckett, L A; Pan, C X; Robles, D; Suga, J M; Sands, J M; Lara, P N Jr